Hyoscyamine is a chemical compound, a tropane alkaloid it is the levo-isomer to atropine. It is a secondary metabolite of some plants. Hyoscyamine is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, pancreatitis, colic and cystitis. It has also been used to relieve some heart problems, control some of the symptoms of Parkinson's disease, as well as for control of respiratory secretions in end of life care.

Market Analysis and Insights: Global Hyoscyamine Market
In 2020, the global Hyoscyamine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Hyoscyamine Scope and Market Size
The global Hyoscyamine market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Hyoscyamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Oral
Injection

Segment by Application
Hospital
Drug Store

By Company
GlaxoSmithKline
Jasper Pharm
Gem Pharmaceuticals
Irza Pharm
Hoechst
Lahore Chemical and Pharmaceutical Works
Genera Pharmaceuticals
Chen-ho Pharmaceuticals
Pfizer
Karo Pharma
Yung Shin Pharmaceutical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE